Paloma Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,634
| Closed | -$349K | – | 640 |
|
|
2022
Q3 | $349K | Buy |
+5,634
| New | +$349K | 0.02% | 186 |
|
|
2022
Q2 | – | Sell |
-2,710
| Closed | -$285K | – | 1539 |
|
|
2022
Q1 | $285K | Sell |
2,710
-3,451
| -56% | -$363K | 0.01% | 872 |
|
|
2021
Q4 | $664K | Sell |
6,161
-1,358
| -18% | -$146K | 0.01% | 750 |
|
|
2021
Q3 | $824K | Sell |
7,519
-24,412
| -76% | -$2.68M | 0.02% | 316 |
|
|
2021
Q2 | $2.99M | Buy |
+31,931
| New | +$2.99M | 0.05% | 199 |
|
|
2021
Q1 | – | Sell |
-8,842
| Closed | -$647K | – | 2186 |
|
|
2020
Q4 | $647K | Sell |
8,842
-127,091
| -93% | -$9.3M | 0.02% | 593 |
|
|
2020
Q3 | $10.6M | Buy |
135,933
+126,903
| +1,405% | +$9.86M | 0.27% | 33 |
|
|
2020
Q2 | $502K | Buy |
+9,030
| New | +$502K | 0.01% | 1091 |
|
|
2019
Q4 | – | Sell |
-34,508
| Closed | -$940K | – | 2234 |
|
|
2019
Q3 | $940K | Sell |
34,508
-461,811
| -93% | -$12.6M | 0.02% | 577 |
|
|
2019
Q2 | $11.9M | Buy |
+496,319
| New | +$11.9M | 0.2% | 70 |
|
|
2018
Q2 | – | Sell |
-28,447
| Closed | -$404K | – | 1819 |
|
|
2018
Q1 | $404K | Buy |
+28,447
| New | +$404K | 0.01% | 1020 |
|
|
2017
Q4 | – | Sell |
-19,180
| Closed | -$243K | – | 1756 |
|
|
2017
Q3 | $243K | Buy |
+19,180
| New | +$243K | ﹤0.01% | 1308 |
|
|
2017
Q2 | – | Sell |
-12,161
| Closed | -$180K | – | 1949 |
|
|
2017
Q1 | $180K | Sell |
12,161
-16,410
| -57% | -$243K | ﹤0.01% | 1402 |
|
|
2016
Q4 | $462K | Buy |
+28,571
| New | +$462K | ﹤0.01% | 1104 |
|